Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments

Condensed Interim Consolidated Statements of Cash Flows (Unaudited)

v3.21.2
Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2021
Jun. 30, 2020
Operating    
Net loss $ (15,734) $ (1,911)
Non-cash items    
Depreciation and amortization 235 49
Interest expense on lease liabilities 33
Stock-based compensation expense 2,198 435
Loss on change in fair value of warrants 1,994 7,629
Non-cash issue costs 764
Non-cash settlement included in payables 2,090
Accrued interest on Note payable 76 154
Changes in non-cash working capital balances    
Prepaid expenses and deposits (426) (594)
Accounts payable and accrued liabilities (2,424) (4,876)
Cash (used in) provided by operating activities (14,048) 3,740
Financing    
Exercise of Derivative warrants 8,000
January 2021 Equity Offering, net of issuance costs 10,231
February 2021 Equity Offering, net of issuance costs 21,093
Exercise of Equity warrants 1,985
Exercise of stock options 14
Net proceeds from issuance of common shares 2,524 22,749
Note payable 174 1,500
Repayment of lease liabilities (102) (10)
Cash provided by financing activities 43,919 24,239
Investing    
Purchase of property, plant and equipment (152)
Purchase of patents (183) (103)
Cash used in investing activities (335) (103)
Increase in cash and cash equivalents 29,536 27,876
Cash and cash equivalents, beginning of the period 25,469 814
Cash and cash equivalents, end of the period $ 55,005 $ 28,690